Amber Arnold

1.2k total citations
23 papers, 619 citations indexed

About

Amber Arnold is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Amber Arnold has authored 23 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Amber Arnold's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (5 papers) and Infectious Diseases and Tuberculosis (5 papers). Amber Arnold is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (5 papers) and Infectious Diseases and Tuberculosis (5 papers). Amber Arnold collaborates with scholars based in United Kingdom, Germany and United States. Amber Arnold's co-authors include Philip D. Butcher, Adam A. Witney, Jason Hinds, Catherine A. Cosgrove, Neil G. Stoker, Christine Carney, Thomas S. Harrison, Shauna Downs, Noreen D. Willows and Kim D. Raine and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and BMC Medicine.

In The Last Decade

Amber Arnold

23 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amber Arnold United Kingdom 13 306 231 147 96 69 23 619
Jeffrey A. Tornheim United States 18 510 1.7× 447 1.9× 133 0.9× 58 0.6× 92 1.3× 43 943
Mehmet Faruk Geyik Türkiye 16 88 0.3× 286 1.2× 98 0.7× 30 0.3× 52 0.8× 48 587
Kelly Cawcutt United States 16 191 0.6× 326 1.4× 101 0.7× 63 0.7× 45 0.7× 53 807
Susan A. Dolan United States 15 187 0.6× 193 0.8× 90 0.6× 104 1.1× 44 0.6× 31 676
Robin Bruyndonckx Belgium 15 140 0.5× 275 1.2× 210 1.4× 64 0.7× 44 0.6× 47 731
Steve Blum United States 18 384 1.3× 331 1.4× 139 0.9× 94 1.0× 53 0.8× 35 962
İ̇lker İnanç Balkan Türkiye 19 445 1.5× 265 1.1× 87 0.6× 41 0.4× 77 1.1× 81 1.1k
Naomi Runnegar Australia 14 144 0.5× 156 0.7× 110 0.7× 82 0.9× 56 0.8× 35 928
Periklis Panagopoulos Greece 15 208 0.7× 152 0.7× 111 0.8× 29 0.3× 47 0.7× 80 729
Genève Allison United States 17 236 0.8× 196 0.8× 249 1.7× 56 0.6× 105 1.5× 25 1.1k

Countries citing papers authored by Amber Arnold

Since Specialization
Citations

This map shows the geographic impact of Amber Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Arnold more than expected).

Fields of papers citing papers by Amber Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Arnold. The network helps show where Amber Arnold may publish in the future.

Co-authorship network of co-authors of Amber Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Amber Arnold. A scholar is included among the top collaborators of Amber Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber Arnold. Amber Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gustafson, Owen, Elizabeth King, Michael Maia Schlüssel, et al.. (2024). The impact of musculoskeletal ill health on quality of life and function after critical care: a multicentre prospective cohort study. Anaesthesia. 79(8). 821–828. 3 indexed citations
2.
Youngs, Jonathan & Amber Arnold. (2021). Infections in the immunocompromised host: secondary immunodeficiency disorders. Medicine. 49(10). 611–617. 2 indexed citations
3.
Arnold, Amber & Eithne MacMahon. (2021). Adenovirus infections. Medicine. 49(12). 790–793. 2 indexed citations
4.
Sturdy, Ann, David Shakespeare, Nirav R. Shah, et al.. (2020). Severe COVID-19 and healthcare-associated infections on the ICU: time to remember the basics?. Journal of Hospital Infection. 105(4). 593–595. 34 indexed citations
5.
Evans, Terry John, et al.. (2020). Antibiotic usage and stewardship in patients with COVID-19: too much antibiotic in uncharted waters?. Journal of Infection Prevention. 22(3). 119–125. 17 indexed citations
6.
Green, Nathan, Amber Arnold, Graham Cooke, et al.. (2019). A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK. Journal of Infection. 80(1). 38–41. 5 indexed citations
7.
Konstantinow, A., Amber Arnold, W. Kempf, et al.. (2017). Therapy of ulcus cruris of venous and mixed venous arterial origin with autologous, adult, native progenitor cells from subcutaneous adipose tissue: a prospective clinical pilot study. Journal of the European Academy of Dermatology and Venereology. 31(12). 2104–2118. 27 indexed citations
8.
Arnold, Amber, Graham Cooke, Onn Min Kon, et al.. (2017). Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 61(9). 34 indexed citations
9.
Witney, Adam A., Catherine A. Cosgrove, Amber Arnold, et al.. (2016). Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC Medicine. 14(1). 46–46. 81 indexed citations
10.
Arnold, Amber, Graham Cooke, Onn Min Kon, et al.. (2016). Drug resistant TB: UK multicentre study (DRUMS): Treatment, management and outcomes in London and West Midlands 2008–2014. Journal of Infection. 74(3). 260–271. 16 indexed citations
11.
Arnold, Amber, Adam A. Witney, A. Roche, et al.. (2016). XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencing. Journal of Infection. 73(3). 210–218. 27 indexed citations
12.
Witney, Adam A., Katherine A. Gould, Amber Arnold, et al.. (2015). Clinical Application of Whole-Genome Sequencing To Inform Treatment for Multidrug-Resistant Tuberculosis Cases. Journal of Clinical Microbiology. 53(5). 1473–1483. 82 indexed citations
13.
Davies, Alisha, Ruth Ruggles, Yi‐Ho Young, et al.. (2012). Salmonella entericaserovar Enteritidis phage type 4 outbreak associated with eggs in a large prison, London 2009: an investigation using cohort and case/non-case study methodology. Epidemiology and Infection. 141(5). 931–940. 4 indexed citations
14.
Downs, Shauna, et al.. (2009). Associations among the food environment, diet quality and weight status in Cree children in Québec. Public Health Nutrition. 12(9). 1504–1511. 68 indexed citations
15.
Planche, Tim & Amber Arnold. (2009). Clostridium difficile. Medicine. 37(12). 641–643. 3 indexed citations
16.
Arnold, Amber, et al.. (2000). The mercury sphygmomanometer should be abandoned before it is proscribed. Journal of Human Hypertension. 14(1). 31–36. 62 indexed citations
17.
Shaughnessy, Peter W., Kathryn S. Crisler, R E Schlenker, et al.. (1994). Measuring and assuring the quality of home health care.. PubMed. 16(1). 35–67. 46 indexed citations
18.
Arndt, R., Amber Arnold, E. B. Helm, et al.. (1992). Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum. Journal of Molecular Medicine. 70(7). 588–94. 65 indexed citations
19.
Arnold, Amber, Paul Curzon, Robert L. Page, & Simon Williams. (1984). Non-compliance with antituberculous drugs. British Journal of Diseases of the Chest. 78(3). 295–298. 3 indexed citations
20.
Arnold, Amber, et al.. (1978). Cytomegalovirus infection and the Guillain-Barré syndrome. Postgraduate Medical Journal. 54(628). 112–114. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey A. Tornheim Breakdown of academic impact, for papers by Mehmet Faruk Geyik Breakdown of academic impact, for papers by Kelly Cawcutt Breakdown of academic impact, for papers by Susan A. Dolan Breakdown of academic impact, for papers by Robin Bruyndonckx Breakdown of academic impact, for papers by Steve Blum Breakdown of academic impact, for papers by İ̇lker İnanç Balkan Breakdown of academic impact, for papers by Naomi Runnegar Breakdown of academic impact, for papers by Periklis Panagopoulos Breakdown of academic impact, for papers by Genève Allison
Rankless by CCL
2026